LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $255,000 | -31.8% | 39,612 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $374,000 | -76.5% | 39,612 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,594,000 | +46.2% | 79,224 | +112.0% | 0.00% | 0.0% |
| Q2 2018 | $1,090,000 | +15.3% | 37,363 | +17.8% | 0.00% | 0.0% |
| Q1 2018 | $945,000 | -7.4% | 31,722 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,021,000 | -4.8% | 31,722 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $1,073,000 | +16.8% | 30,859 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $919,000 | +21.2% | 30,859 | +21.5% | 0.00% | 0.0% |
| Q1 2017 | $758,000 | +70.3% | 25,390 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $445,000 | -17.3% | 25,390 | +12.4% | 0.00% | 0.0% |
| Q3 2016 | $538,000 | +45.8% | 22,599 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $369,000 | -23.3% | 23,042 | +0.2% | 0.00% | 0.0% |
| Q1 2016 | $481,000 | -22.5% | 22,986 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $621,000 | +33.0% | 22,986 | +36.7% | 0.00% | 0.0% |
| Q3 2015 | $467,000 | +13.3% | 16,817 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | – | 16,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |